19.310
19.31 (0%)
As of Dec 24, 2024
Viridian Therapeutics, Inc.\DE [VRDN]
Source:
Company Overview
Viridian Therapeutics, Inc is a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases. We target under-competitive disease areas where marketed therapies often leave room for improvements in efficacy, safety, and/or dosing convenience.
Country | United States |
Headquarters | waltham, massachusetts |
Phone Number | 617.272.4600 |
Industry | services |
CEO | Stephen Mahoney |
Website | www.viridiantherapeutics.com |